New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

"Only a patient can really appreciate how much ringing the bell matters. So the day he hung it up, it was the most joyous ...

"It's a little overwhelming, but everyone's been so amazing and supportive and it makes me feel really great," junior Taylor LaRoche said, who was diagnosed with Hodgkin's Lymphoma last Christmas Eve ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

Assemblywoman Selena La Rue Hatch announced she submitted a bill draft request aimed at expanding the availability of paid ...

The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.

Blood cancer symptoms can be vague, which is why you might want to look out for a specific sign on your skin. Some people don ...

A terminally ill guide dog was treated to a very special walk on Blackpool Promenade so that he could say goodbye to all his ...

The businesswoman spoke exclusively with PEOPLE about learning how to be more comfortable with bringing more private elements ...